Article

Broadly-recognized, cross-reactive SARS-CoV-2 CD4 T cell epitopes are highly conserved…

bioRxiv: the preprint server for biology · 2022 · Aniuska Becerra-Artiles, author J. Mauricio Calvo-Calle, author Marydawn Co, author Padma P. Nanaware, author John Cruz, author Grant C. Weaver, author Liying Lu, author Catherine Forconi, author Robert W. Finberg, author Ann M. Moormann, author Lawrence J. Stern, author

Key facts

Title Broadly-recognized, cross-reactive SARS-CoV-2 CD4 T cell epitopes are highly conserved across human coronaviruses and presented by common HLA alleles
First author Aniuska Becerra-Artiles, author J. Mauricio Calvo-Calle, author Marydawn Co, author Padma P. Nanaware, author John Cruz, author Grant C. Weaver, author Liying Lu, author Catherine Forconi, author Robert W. Finberg, author Ann M. Moormann, author Lawrence J. Stern, author
Journal bioRxiv : the preprint server for biology
Published Feb 15, 2022
DOI 10.1101/2022.01.20.477107
Devices mentioned BK110039, DEN000008, K022086, K103302, K113566, K800781
Product codes mentioned JCI, JJH, KIT, NDS, NJT, OOI, PFF, PFT, KIS, PCA

At a glance

  • 1–9 FDA submissions mentioned
  • 10–99 Product codes mentioned

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About Literature

Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.

Source: Publisher and PubMed metadata; device mentions identified by Orca1

Browse all Literature